SCHEMBL2866378

SCHEMBL2866378

CS(=O)(=O)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 3/20 0.59
MAPKAPK2 P49137 1/20 0.59
PRKD3 O94806 2/20 0.54
ROCK1 Q13464 2/20 0.54
CLK4 Q9HAZ1 2/20 0.54
CDC7 O00311 1/20 0.54
PLK4 O00444 1/20 0.54
DAPK3 O43293 1/20 0.54
DYRK3 O43781 1/20 0.54
JAK2 O60674 1/20 0.54
ROCK2 O75116 1/20 0.54
MAP4K4 O95819 1/20 0.54
CDK1 P06493 1/20 0.54
ROS1 P08922 1/20 0.54
CDK2 P24941 1/20 0.54
MARK3 P27448 1/20 0.54
TYK2 P29597 1/20 0.54
KDR P35968 1/20 0.54
CLK2 P49760 1/20 0.54
JAK3 P52333 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1461087 0.87 ITK (0.53) ITKMAPKAPK2AURKBMAPK1TTK
SCHEMBL1460755 0.86 MAPK1 (0.61) ITKPRKD3ROCK1CLK4CDC7
SCHEMBL2869839 0.81 MAP2K4 (0.61) ITKPRKD3ROCK1CLK4CDC7
SCHEMBL2861016 0.81 ITK (0.68) ITKMAPKAPK2TTKAURKA
SCHEMBL2857629 0.80 MAP2K4 (0.46) ITKMAPKAPK2PRKD3ROCK1CLK4
SCHEMBL1460955 0.79 KMT2A (0.60) ITKAURKBMAP2K4TTKAURKA
SCHEMBL2870195 0.77 MAP2K4 (0.43) ITKMAPKAPK2PRKD3ROCK1CLK4
SCHEMBL2864712 0.75 ITK (0.56) ITKMAPKAPK2AURKBTTKAURKA
SCHEMBL2864750 0.75 CDK2 (0.43) MAPKAPK2PRKD3ROCK1CLK4CDC7
SCHEMBL4008197 0.75 ITK (0.51) ITKAURKBMAPK1TTKNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ITK 3726/4885MAPKAPK2 18/4885PRKD3 330/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 ITK 3628/4885MAPKAPK2 26/4885PRKD3 961/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ITK 3726/4885MAPKAPK2 18/4885PRKD3 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.